Your browser doesn't support javascript.
loading
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.
Ballard, Peter; Yates, James W T; Yang, Zhenfan; Kim, Dong-Wan; Yang, James Chih-Hsin; Cantarini, Mireille; Pickup, Kathryn; Jordan, Angela; Hickey, Mike; Grist, Matthew; Box, Matthew; Johnström, Peter; Varnäs, Katarina; Malmquist, Jonas; Thress, Kenneth S; Jänne, Pasi A; Cross, Darren.
Afiliação
  • Ballard P; iMED Oncology, AstraZeneca, Macclesfield, United Kingdom. Darren.Cross@astrazeneca.com pbdmpk@gmail.com.
  • Yates JW; iMED Oncology, AstraZeneca, Cambridge, United Kingdom.
  • Yang Z; Asia and Emerging Markets iMED, AstraZeneca, Shanghai, China.
  • Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Yang JC; National Taiwan University Hospital, Taipei City, Taiwan.
  • Cantarini M; Global Medicines Development, AstraZeneca, Macclesfield, United Kingdom.
  • Pickup K; iMED Oncology, AstraZeneca, Macclesfield, United Kingdom.
  • Jordan A; iMED Oncology, AstraZeneca, Macclesfield, United Kingdom.
  • Hickey M; AstraZeneca, Cambridge, United Kingdom.
  • Grist M; iMED Oncology, AstraZeneca, Macclesfield, United Kingdom.
  • Box M; iMED Oncology, AstraZeneca, Macclesfield, United Kingdom.
  • Johnström P; AstraZeneca Translational Science Centre, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Varnäs K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Malmquist J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Thress KS; iMED Oncology, AstraZeneca, Gatehouse Park, Waltham, Massachusetts.
  • Jänne PA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cross D; iMED Oncology, AstraZeneca, Cambridge, United Kingdom. Darren.Cross@astrazeneca.com pbdmpk@gmail.com.
Clin Cancer Res ; 22(20): 5130-5140, 2016 Oct 15.
Article em En | MEDLINE | ID: mdl-27435396
Buscar no Google
Base de dados: MEDLINE Assunto principal: Piperazinas / Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Piperazinas / Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article